Skip to main content

VWR Buys Biochemical, Reagent Firm Amresco

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – VWR International today announced the acquisition of Amresco for an undisclosed amount.

Based in Solon, Ohio, Amresco manufactures and supplies biochemicals and reagents for use in research in the molecular biology, life sciences, proteomics, clinical, and histology markets.

The addition of Amresco expands VWR's product portfolio, Matt Malenfant, VWR senior vice president and president of North America, Lab Business and Services, said in a statement. He added that Amresco's "expertise plays well with our increased focus on chemical and life science applications and will provide our customers greater choice and value."

VWR is a global laboratory supply and distribution firm based in Radnor, Penn. It generated worldwide sales of $3.5 billion in 2009.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.